Hecker M - Search Results

1

Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks.

Goertsches RH, Hecker M, Zettl UK. Goertsches RH, et al. Among authors: hecker m. J Neurol. 2008 Dec;255 Suppl 6:48-57. doi: 10.1007/s00415-008-6010-1. J Neurol. 2008. PMID: 19300960 Review.

2

Integrative modeling of transcriptional regulation in response to antirheumatic therapy.

Hecker M, Goertsches RH, Engelmann R, Thiesen HJ, Guthke R. Hecker M, et al. BMC Bioinformatics. 2009 Aug 24;10:262. doi: 10.1186/1471-2105-10-262. BMC Bioinformatics. 2009. PMID: 19703281 Free PMC article.

3

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

Goertsches RH, Hecker M, Koczan D, Serrano-Fernandez P, Moeller S, Thiesen HJ, Zettl UK. Goertsches RH, et al. Among authors: hecker m. Pharmacogenomics. 2010 Feb;11(2):147-61. doi: 10.2217/pgs.09.152. Pharmacogenomics. 2010. PMID: 20136355

4

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.

Hecker M, Goertsches RH, Fatum C, Koczan D, Thiesen HJ, Guthke R, Zettl UK. Hecker M, et al. Pharmacogenomics J. 2012 Apr;12(2):134-46. doi: 10.1038/tpj.2010.77. Epub 2010 Oct 19. Pharmacogenomics J. 2012. PMID: 20956993

5

Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.

Goertsches RH, Zettl UK, Hecker M. Goertsches RH, et al. Among authors: hecker m. Pharmacogenomics. 2011 Mar;12(3):423-32. doi: 10.2217/pgs.10.190. Pharmacogenomics. 2011. PMID: 21449680

6

Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.

Hecker M, Lorenz P, Steinbeck F, Hong L, Riemekasten G, Li Y, Zettl UK, Thiesen HJ. Hecker M, et al. Autoimmun Rev. 2012 Jan;11(3):180-90. doi: 10.1016/j.autrev.2011.05.010. Epub 2011 May 18. Autoimmun Rev. 2012. PMID: 21621003 Review.

7

MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

Thamilarasan M, Koczan D, Hecker M, Paap B, Zettl UK. Thamilarasan M, et al. Among authors: hecker m. Autoimmun Rev. 2012 Jan;11(3):174-9. doi: 10.1016/j.autrev.2011.05.009. Epub 2011 May 18. Autoimmun Rev. 2012. PMID: 21621006 Review.

8

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.

Hecker M, Paap BK, Goertsches RH, Kandulski O, Fatum C, Koczan D, Hartung HP, Thiesen HJ, Zettl UK. Hecker M, et al. PLoS One. 2011;6(12):e29648. doi: 10.1371/journal.pone.0029648. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216338 Free PMC article.

9

Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Angerstein C, Hecker M, Paap BK, Koczan D, Thamilarasan M, Thiesen HJ, Zettl UK. Angerstein C, et al. Among authors: hecker m. Mol Neurobiol. 2012 Jun;45(3):520-35. doi: 10.1007/s12035-012-8270-0. Epub 2012 May 2. Mol Neurobiol. 2012. PMID: 22549745

10

An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patients.

Paap BK, Hundeshagen A, Hecker M, Zettl UK. Paap BK, et al. Among authors: hecker m. Curr Pharm Des. 2012;18(29):4475-84. doi: 10.2174/138161212802502215. Curr Pharm Des. 2012. PMID: 22612748 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,212 results

Search Page

Filters